• CROI: Changes in markers of T-cell Senescence and Exhaustion With HIV Therapy - (02/21/20)
   
  
• Aging of HIV+ in US.....an epidemic coming - (02/21/20)
   
  
• Multiple roles for HIV broadly neutralizing antibodies - (02/21/20)
   
  
• Understanding The Relationship Between HPV and Anal Cancer - (02/14/20)
   
  
• Loss of Preexisting Immunological Memory Among Human Immunodeficiency Virus-Infected Women Despite Immune Reconstitution With Antiretroviral Therapy - (02/14/20)
   
  
• Novel Antiretroviral Agents - (02/14/20)
   
  
• Increased Healthcare Costs for Older HIV+ - (02/10/20)
   
  
• The HIV Continuum of Care for Adolescents and Young Adults Attending 13 Urban US HIV Care Centers of the NICHD-ATN-CDC-HRSA SMILE Collaborative..... - (02/10/20)
   
  
• Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV - (02/10/20)
   
  
• Preexposure Prophylaxis Indication Criteria Underidentify Black and Latinx Persons and Require Revision - (02/07/20)
   
  
• Functional Interval Training for Veterans Exercising Through Telehealth. (FIT-VET) - (02/06/20)
   
  
• Antiretroviral therapy in older people with HIV - HIV AND AGING: Edited by Kristine M. Erlandson - (02/04/20)
   
  
• Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV - (02/04/20)
   
  
More HIV Articles...
 

• China Launches 3 Remdesivir Trials - (02/14/20)
   
  
• Gilead joins GSK, J&J in offering coronavirus vaccine options - (02/14/20)
   
  
• CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus - (02/14/20)
   
  
• Johnson & Johnson Announces Collaboration with U.S. Department of Health & Human Services to Accelerate Development of a Potential Novel Coronavirus Vaccine - (02/14/20)
   
  
More News Updates Articles...
 

• HCV & HCV/HIV Coinfection Micro-Elimination Grants: funding for 30+ projects - -
   
  
• EASL: Summary from EASL 2018 for Hepatitis C (HCV) HCV in 2018: Success stories and remaining challenges? - Prof. Dr. J.K. Rockstroh Department of Medicine I University of Bonn Sigmund-Freud-Str. 25 53105 Bonn Germany-
   
  
• EASL: HCV Micro-Elimination Funding Grants Available
   
  
• The cost of eliminating hepatitis C in Pakistan Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysis - (02/21/20)
   
  
• AbbVie Receives Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks in Genotype 3, Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis - (02/14/20)
   
  
• 20% Treated - Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore - (02/10/20)
   
  
• AASLD: Assessing the Real-World Effectiveness and Clinical Efficacy of 8198 Patients Receiving Elbasvir/Grazoprevir for the Treatment of HCV Infection - (02/03/20)
   
  
• HCV in USA Current Status - (01/30/20)
   
  
• USA is last globally in HCV Elimination - (01/30/20)
   
  
• Sexually Acquired Hepatitis C Infection in HIV-Uninfected Men Who Have Sex With Men Using Preexposure Prophylaxis Against HIV - (01/17/20)
   
  
• Acute HCV & PrEP/MSM HIV+ & HIV-Neg - (01/17/20)
   
  
• EACS: High HCV re infection rate in MSM living with HIV in Barcelona: The need to focus on high risk population to achieve HCV elimination (01/17/20)
   
  
More Hep C Articles...
 

• HBV Cure Therapies Research - (01/23/20)
   
  
• AASLD: Impact of Prior Tenofovir Disoproxil Fumarate Treatment Duration on Tenofovir Alafenamide Safety Profile in Virally Suppressed, Chronic HBV Patients Switched From TDF to TAF - (12/13/19)
   
  
• AASLD: Efficacy and Safety of Oral TLR8 Agonist Selgantolimod in Virally Suppressed Adult Patients With Chronic Hepatitis B: a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study - (12/12/19)
   
  
More Hep B Articles...
 

List not necessarily listed here in order of date being held.